14-Nov-2025 6:15 AM CST - Business Wire Twist Bioscience Announces Fiscal 2025 Fourth Quarter and Full Year Financial Results Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced financial results and business highlights for the fourth quarter and full year fiscal 2025 ended September 30, 2025. Visit the Events and Presentations page of the Investor Relations section under the Company tab at www.twistbioscience.com to view the detailed fiscal fourth quarter and full year 2025 earnings report and the investor presentatio
4-Nov-2025 7:00 AM CST - Business Wire Twist Bioscience to Present at 7th Annual Wolfe Research Healthcare Conference Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience and Adam Laponis, CFO of Twist, will participate in a fireside chat at the at 7th Annual Wolfe Research Healthcare Conference on Monday, November 17, 2025 at 3:20 pm Eastern Time in New York City. The fireside chat will be webcast live and can be accessed by visiting the Inves
23-Oct-2025 7:00 AM CST - Business Wire Twist Bioscience to Report Fiscal 2025 Fourth Quarter and Full Year Financial Results on Friday, November 14, 2025 Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that it will issue its financial results for the fiscal 2025 fourth quarter and full year ended September 30, 2025, before the opening of the market on November 14, 2025. The company plans to hold a conference call and live audio webcast for analysts and investors at 8:00 a.m. Eastern Time to discuss its financial results and provide an update on
3-Sep-2025 7:00 AM CST - Business Wire Twist Bioscience to Present at Baird 2025 Global Healthcare Conference Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will present at the Baird 2025 Global Healthcare Conference on Tuesday, September 9, 2025 at 9:40 am Eastern Time in New York City. The company will also host one-on-one meetings at the Morgan Stanley 23rd Annual Global Healthcare Conference on Wednesday, September 10, 2025. T
4-Aug-2025 6:15 AM CST - Business Wire Twist Bioscience Announces Fiscal 2025 Third Quarter Financial Results Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth equity, today announced financial results and business highlights for the third quarter fiscal 2025 ended June 30, 2025. A strong balance sheet and disciplined cost-management underpin our focused business execution, said Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience. Visit the Events and Presentations page of the Investor Relations section under the Company ta
14-Jul-2025 7:00 AM CST - Business Wire Twist Bioscience to Report Fiscal 2025 Third Quarter Financial Results on Monday, August 4, 2025 Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced that it will issue its financial results for the fiscal 2025 third quarter ended June 30, 2025, before the opening of the market on August 4, 2025. The company plans to hold a conference call and live audio webcast for analysts and investors at 8:00 a.m. Eastern Time to discuss its financ
15-May-2025 7:00 AM CST - Business Wire Twist Bioscience to Present at William Blair 45th Annual Growth Stock Conference Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced that Patrick Finn, Ph.D., president and COO of Twist Bioscience, will present at the William Blair 45th Annual Growth Stock Conference on Tuesday June 3, 2025 at 10:00 am Central Time in Chicago, Illinois. The presentation will be webcast live and can be accessed by visiting the Investor
5-May-2025 6:15 AM CST - Business Wire Twist Bioscience Announces Fiscal 2025 Second Quarter Financial Results Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced financial results and business highlights for the second quarter fiscal 2025 ended March 31, 2025. Visit the Events and Presentations page of the Investor Relations section under the Company tab at www.twistbioscience.com to view the detailed fiscal second quarter 2025 earnings report a
5-May-2025 6:10 AM CST - Business Wire Twist Bioscience Spins Out DNA Data Storage as Independent Company Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced that the company has spun out its DNA data storage technology application as an independent company, named Atlas Data Storage (Atlas). There are many applications of synthetic DNA with the potential to have an incredible impact on the world. With this spin out, both Twist and Atlas are
14-Nov-2025 6:15 AM CST - Business Wire Twist Bioscience Announces Fiscal 2025 Fourth Quarter and Full Year Financial Results Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced financial results and business highlights for the fourth quarter and full year fiscal 2025 ended September 30, 2025. Visit the Events and Presentations page of the Investor Relations section under the Company tab at www.twistbioscience.com to view the detailed fiscal fourth quarter and full year 2025 earnings report and the investor presentatio
4-Nov-2025 7:00 AM CST - Business Wire Twist Bioscience to Present at 7th Annual Wolfe Research Healthcare Conference Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience and Adam Laponis, CFO of Twist, will participate in a fireside chat at the at 7th Annual Wolfe Research Healthcare Conference on Monday, November 17, 2025 at 3:20 pm Eastern Time in New York City. The fireside chat will be webcast live and can be accessed by visiting the Inves
23-Oct-2025 7:00 AM CST - Business Wire Twist Bioscience to Report Fiscal 2025 Fourth Quarter and Full Year Financial Results on Friday, November 14, 2025 Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that it will issue its financial results for the fiscal 2025 fourth quarter and full year ended September 30, 2025, before the opening of the market on November 14, 2025. The company plans to hold a conference call and live audio webcast for analysts and investors at 8:00 a.m. Eastern Time to discuss its financial results and provide an update on
3-Sep-2025 7:00 AM CST - Business Wire Twist Bioscience to Present at Baird 2025 Global Healthcare Conference Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will present at the Baird 2025 Global Healthcare Conference on Tuesday, September 9, 2025 at 9:40 am Eastern Time in New York City. The company will also host one-on-one meetings at the Morgan Stanley 23rd Annual Global Healthcare Conference on Wednesday, September 10, 2025. T
4-Aug-2025 6:15 AM CST - Business Wire Twist Bioscience Announces Fiscal 2025 Third Quarter Financial Results Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth equity, today announced financial results and business highlights for the third quarter fiscal 2025 ended June 30, 2025. A strong balance sheet and disciplined cost-management underpin our focused business execution, said Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience. Visit the Events and Presentations page of the Investor Relations section under the Company ta
14-Jul-2025 7:00 AM CST - Business Wire Twist Bioscience to Report Fiscal 2025 Third Quarter Financial Results on Monday, August 4, 2025 Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced that it will issue its financial results for the fiscal 2025 third quarter ended June 30, 2025, before the opening of the market on August 4, 2025. The company plans to hold a conference call and live audio webcast for analysts and investors at 8:00 a.m. Eastern Time to discuss its financ
15-May-2025 7:00 AM CST - Business Wire Twist Bioscience to Present at William Blair 45th Annual Growth Stock Conference Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced that Patrick Finn, Ph.D., president and COO of Twist Bioscience, will present at the William Blair 45th Annual Growth Stock Conference on Tuesday June 3, 2025 at 10:00 am Central Time in Chicago, Illinois. The presentation will be webcast live and can be accessed by visiting the Investor
5-May-2025 6:15 AM CST - Business Wire Twist Bioscience Announces Fiscal 2025 Second Quarter Financial Results Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced financial results and business highlights for the second quarter fiscal 2025 ended March 31, 2025. Visit the Events and Presentations page of the Investor Relations section under the Company tab at www.twistbioscience.com to view the detailed fiscal second quarter 2025 earnings report a
5-May-2025 6:10 AM CST - Business Wire Twist Bioscience Spins Out DNA Data Storage as Independent Company Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced that the company has spun out its DNA data storage technology application as an independent company, named Atlas Data Storage (Atlas). There are many applications of synthetic DNA with the potential to have an incredible impact on the world. With this spin out, both Twist and Atlas are
